Please use this identifier to cite or link to this item: 10.32607/20758251-2013-5-1-85-89
Title: Overexpression of MRPS18-2 in cancer cell lines results in appearance of multinucleated cells
Authors: Shevchuk, Z.
Yurchenko, M. Y.
Darekar, S. D.
Holodnuka-Kholodnyuk, I.
Kashuba, V. I.
Kashuba, E. V.
Institute of Microbiology and Virology
Keywords: Cancer cell line;Cell cycle;Mitochondrial ribosomal protein S18-2 (MRPS18-2);Multinucleated cells;RB binding protein;1.6 Biological sciences;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;Biotechnology;Biochemistry;Molecular Medicine;Molecular Biology;SDG 3 - Good Health and Well-being
Issue Date: 2013
Citation: Shevchuk , Z , Yurchenko , M Y , Darekar , S D , Holodnuka-Kholodnyuk , I , Kashuba , V I & Kashuba , E V 2013 , ' Overexpression of MRPS18-2 in cancer cell lines results in appearance of multinucleated cells ' , Acta Naturae , vol. 5 , no. 16 , pp. 85-89 . https://doi.org/10.32607/20758251-2013-5-1-85-89
Abstract: Human mitochondrial ribosomal protein MRPS18-2 (S18-2) is encoded by a cellular gene that is located on the human chromosome 6p21.3. We discovered that overexpression of the S18-2 protein led to immortalization and de-differentiation of primary rat embryonic fibroblasts. Cells showed anchorage-independent growth pattern. Moreover, pathways characteristic for rapidly proliferating cells were upregulated then. It is possible that the S18-2 overexpression induced disturbance in cell cycle regulation. We found that overexpression of S18-2 protein in human cancer cell lines led to an appearance of multinucleated cells in the selected clones.
Description: Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
DOI: 10.32607/20758251-2013-5-1-85-89
ISSN: 2075-8251
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Overexpression_of_MRPS18_2_in_Cancer_Cell.pdf10.19 MBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.